Elion, an AI-driven research platform for healthcare technology, recently raised $9.3 million in an oversubscribed seed round, led by NEA and joined by Cedars-Sinai Health Ventures, TMV, Scrub Capital, and Alumni Ventures.
As healthcare technology evolves, providers face pressure to make faster, informed decisions, often lacking the necessary resources. Elion aims to be the go-to platform for healthcare leaders by offering reliable insights into emerging technologies and vendors. By combining a comprehensive dataset of vendors with expertise in health system workflows, Elion provides quick, high-quality guidance to decision-makers.
Elion’s vendor marketplace is now used by over 60% of U.S. health systems, with usage increasing fivefold in the past year, reflecting growing trust in the platform.
How the funding will be used: The new funding will advance platform development, launch new products, and expand Elion’s reach, while the team will grow in engineering, research, and marketing.
KEY QUOTES:
“We’re reimagining what a technology research and advisory business looks like in the age of generative AI. The starting point is our vendor marketplace, which has quickly become the go-to resource for health systems and provider organizations trying to make sense of a crowded and fast-changing landscape. The depth of our vendor and product intelligence, combined with our ability to deliver it in a structured, accessible format, is helping healthcare leaders make better, faster decisions.”
Bobby Guelich, Elion’s CEO and cofounder
“Elion gives me a clear, structured view of the health tech landscape—without the noise. It helps me quickly identify the right partners to advance our digital and innovation goals.”
Tom Maddox, MD SM, Vice President of Digital Products & Innovation at BJC
“Cedars Sinai Health Ventures is excited to partner with Elion as they empower healthcare leaders with the insights they need to navigate an increasingly complex vendor landscape. We believe Elion is poised to become a valuable tool for healthtech intelligence—helping hospitals, investors, and innovators make smarter, data-driven choices.”
Maureen Burgess, Partner at Cedars Sinai Health Ventures
“GenAI created a surge of health tech solutions. But adoption has lagged as providers face an overwhelming array of high-stakes choices and time-consuming research. Elion accelerates tech adoption and time-to-value so providers can focus on taking care of patients, not applications. We’re thrilled to continue partnering with Bobby and the Elion team as they build the go-to platform for healthcare technology decision-makers.”
Michael Li, Principal at NEA
